Enanta Pharmaceuticals
ENTA
#7285
Rank
S$0.60 B
Marketcap
S$20.88
Share price
5.33%
Change (1 day)
141.87%
Change (1 year)

Earnings for Enanta Pharmaceuticals (ENTA)

Earnings in 2025 (TTM): -S$0.11 Billion

According to Enanta Pharmaceuticals 's latest financial reports the company's current earnings are S$65.32 Million. In 2024 the company made an earning of -S$0.13 Billion, an increase over its 2023 earnings that were of -S$0.17 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Enanta Pharmaceuticals from 2012 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$0.11 Billion-19.84%
2024 -S$0.13 Billion-23.87%
2023 -S$0.17 Billion4.39%
2022 -S$0.16 Billion-4.4%
2021 -S$0.17 Billion91.12%
2020 -S$86.07 Million-407.13%
2019 S$28.02 M-78.63%
2018 S$0.13 B117.97%
2017 S$60.16 M-574.65%
2016 -S$12.68 Million-110.83%
2015 S$0.11 B-4.5%
2014 S$0.12 B-638.53%
2013 -S$22.77 Million-137.98%
2012 S$59.93 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
AbbVie
ABBV
S$2.13 B-2,288.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$41.73 B-42,800.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
S$5.74 B-5,980.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$29.74 B-30,534.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$10.34 B-10,688.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$21.15 B-21,741.54%๐Ÿ‡จ๐Ÿ‡ญ Switzerland